Stephen Venter
15 posts
With over ten years of experience covering finance and technology topics, Steven is an established tech and finance journalist, covering consumer finance, stocks, and technology topics.
With an economics degree from the University of London, he has the insight and expertise to decipher complex financial and technical topics and to make them accessible to all readers.
Steven is known for his knack for identifying market trends within the tech industry and effectively communicating their investment relevance.
Microsoft’s Groundbreaking Activision Deal Near Completion
Microsoft is one step closer to completing its ground-breaking $69 billion acquisition of gaming giant Activision Blizzard. The…
Best Quantum AI Stocks In 2023
Stay ahead of the curve with weinvests.com's curated list of the best AI stocks in 2023. Capitalize on the AI revolution and make informed investment decisions.
Prominent Authors Take Legal Action: Another OpenAI Lawsuit
In a landmark move, a consortium of well-known U.S. authors, including luminaries such as John Grisham, George R.R.…
U.S. Homebuilder Confidence Hits Five-Month Low Amid Rising Mortgage Rates
In a concerning revelation for the U.S. housing market, homebuilder sentiment has dipped to its lowest point since…
U.S. Autoworkers Launch Sweeping Strike at Major Auto Firms
On Friday, the United Auto Workers union began a massive labor movement, initiating strikes across three major automobile…
Arm’s +25% Nasdaq Debut: A Glimpse into the Resurgence of IPOs
On September 14, 2023, the Nasdaq Market buzzed with excitement as Softbank’s Arm, a leading chip design firm,…
US FDA Greenlights Updated COVID Vaccines from Pfizer and Moderna
In the ongoing battle against COVID, major pharma continues to see strong vaccine revenue as the U.S. Food…
Apple’s Market Value Slips Amid China Clampdown
The ongoing tussle between the U.S. and China in the tech arena has taken a sharp turn, with…
Roku Announces Major Layoffs, Stock Trends Up
Streaming titan Roku announced a significant decision to lay off 10% of its workforce, the third such round…
The FTC’s Clearance of Amgen’s $28B Deal: A Harbinger for Pharma?
The recent Federal Trade Commission’s (FTC) decision to permit Amgen’s colossal $27.8 billion acquisition of Horizon Therapeutics, albeit…